Natural Agonists of Ryanodine Receptors: Structure-function Relationship and Antiarrhythmic Properties
兰尼定受体的天然激动剂:结构-功能关系和抗心律失常特性
基本信息
- 批准号:9905552
- 负责人:
- 金额:$ 46.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAcuteAdrenergic alpha-AntagonistsAffinityAgonistAmino AcidsAnimal ModelAnimalsArrhythmiaBindingBinding SitesCalciumCalcium ChannelCardiac MyocytesCardiomyopathiesCatecholaminergic Polymorphic Ventricular TachycardiaCell physiologyCellsCellular MembraneCentral Core MyopathyCharacteristicsChargeCommunitiesComplexDisadvantagedDissociationDoseEnzyme ActivationFunctional disorderGenerationsGoalsHeartHeart failureHyperactive behaviorIonsKineticsLigandsLocationMalignant hyperpyrexia due to anesthesiaMapsMetabolicMolecularMuscle CellsMyocardiumNamesPenetrationPeptidesPharmacologyPlant alkaloidPlayPropertyProteinsReceptor ActivationRecombinantsRegulationResearchRoleRyR2RyanodineRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSarcoplasmic ReticulumScorpion VenomsScorpionsSignal TransductionSkeletal MuscleSpecificitySpeedStructureStructure-Activity RelationshipSyndromeTestingTranscriptional RegulationVenomsVentriculardipole momentexperimental studyfunctional groupimperatoxin Amultidisciplinarymutantnovelpreventprogramsreceptorreceptor functionreceptor structure functionsuccessthermostability
项目摘要
ABSTRACT
Ryanodine receptors (RyR) are sarcoplasmic reticulum Ca2+ release channels that play a critical role in
Ca2+ signaling of excitable and non-excitable cells. RyRs owe their name to the fact that they were characterized in
great part thanks to ryanodine, a plant alkaloid that binds to RyRs with high affinity and specificity. Ryanodine has
been an invaluable ligand of RyRs, but its functional effects are complex and hamper its use in cellular studies. In
search of novel ligands that could overcome some of the functional and structural disadvantages of ryanodine, we
found in the venom of selected scorpions a set of peptide ligands, termed calcins, displaying high affinity and
exquisite selectivity against RyRs. The defining characteristic of calcins is their capacity to stabilize RyR openings in
a long-lasting subconducting state. This effect is nearly analogous to that of ryanodine, but unlike ryanodine, calcins
bind rapidly to RyRs (fast association rate), freely dissociate from their binding site (reversible effect), display a dose-
and sequence-variable effect, and are amenable for derivatization without undergoing major loss in receptor affinity.
Calcins also modulate intracellular Ca2+ in intact cardiomyocytes with remarkable speed and with several degrees of
potency, thus entering the field as the first cell-penetrating peptides (CPP) RyR-specific Ca2+ mobilizer of high
dynamic range. This research program will characterize first and then exploit this novel group of peptide ligands to
unravel fundamental mechanisms of RyR function at the molecular, cellular and whole heart level. Our multidisciplinary
program, with well-defined deliverables and milestones, may be enveloped in two specific aims. In the first aim, we
will first identify and modify the structural domains of calcins involved in RyR recognition and cell penetration to
generate a group of functionally diverse CPPs capable of modulating RyR function with wide dynamic range and of
delivering cargo to the interior of cardiomyocytes. In the second aim, we will use native and mutant calcins on intact
cardiomyocytes, Langendorff-perfused working hearts and intact animals to create acute or sustained periods of RyR
hyperactivity and reveal mechanisms of RyR gating, SR Ca2+ load and Ca2+-triggered arrhythmias. These studies use
animal models of catecholaminergic polymorphic ventricular tachycardia to develop a novel paradigm for the treatment
of calcium-dependent arrhythmias; results may be applied to other cardiomyopathies where controlled unloading of
SR Ca2+ may be desirable.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hector H Valdivia其他文献
Hector H Valdivia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hector H Valdivia', 18)}}的其他基金
Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural Peptides
基于天然肽的高亲和力兰尼定受体配体的冷冻电镜结构的合理设计
- 批准号:
10729564 - 财政年份:2023
- 资助金额:
$ 46.32万 - 项目类别:
2017 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2017肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
9331041 - 财政年份:2017
- 资助金额:
$ 46.32万 - 项目类别:
Natural Agonists of Ryanodine Receptors: Structure-function Relationship and Antiarrhythmic Properties
兰尼定受体的天然激动剂:结构-功能关系和抗心律失常特性
- 批准号:
9650244 - 财政年份:2017
- 资助金额:
$ 46.32万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8301588 - 财政年份:2011
- 资助金额:
$ 46.32万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8464216 - 财政年份:2011
- 资助金额:
$ 46.32万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8098484 - 财政年份:2011
- 资助金额:
$ 46.32万 - 项目类别:
Calcins as Membrane-permeable Ligands of Ryanodine Receptors
钙素作为瑞尼定受体的膜渗透性配体
- 批准号:
8663945 - 财政年份:2011
- 资助金额:
$ 46.32万 - 项目类别:
Modulation of Cardiac E-C Coupling by Sorcin
Sorcin 对心脏 E-C 耦合的调节
- 批准号:
6777329 - 财政年份:2004
- 资助金额:
$ 46.32万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 46.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 46.32万 - 项目类别:
Standard Grant














{{item.name}}会员




